Slides
Page 1
30 OCTOBER 2025 Q3 2025 RESULTS
Page 2
| This document is for information purposes only and does not constitute an offer to sell, exchange or buy, or an invitation to make offers to buy, securities issued by any of the companies mentioned. This financial information has been prepared in accordance with international financial reporting standards (IFRS). However, as it has not been audited, the information is not definitive and may be modified in the future. The assumptions, information and forecasts contained herein do not guarantee future results and are exposed to risks and uncertainties; actual results may differ significantly from those used in the assumptions and forecasts for various reasons. The information in this document may contain statements regarding future intentions, expectations or projections. All statements, other than those based on historical facts, are forward-looking statements, including, without limitation, those regarding our financial position, business strategy, management plans and objectives for future operations. Such forward-looking statements are affected, as such, by risks and uncertainties, which could mean that what actually happens does not correspond to them. These risks include, amongst others, seasonal fluctuations that may change demand, industry competition, economic and legal conditions, tariffs or restrictions on free trade and/or political instability in the markets where the Fluidra group operates or in those countries where the group's products are manufactured or distributed. Fluidra makes no commitment to issue updates or revisions concerning the forward-looking statements included in this financial information or concerning the expectations, events, conditions or circumstances on which these forward-looking statements are based. In any event, Fluidra provides information on these and other factors that may affect the company's forward-looking statements, business and financial results in documents filed with the Spanish national securities market commission. We invite all interested persons or entities to consult these documents. Alternative Performance Measures (APMs) This document and any related conference call or webcast (including a Q&A session) contain, in addition to the financial information prepared in accordance with IFRS, alternative performance measures (‘APMs’) as defined in the Guidelines issued by the European Securities and Markets Authority (‘ESMA’) on October 5, 2015. APMs are used by Fluidra’s management to evaluate the group’s financial performance, cash flows or financial position in making operational and strategic decisions for the group and therefore are useful information for investors and other stakeholders. Certain key APMs form part of executive directors, management and employees’ remuneration targets. APMs are prepared on a consistent basis for the periods presented in this document. They should be considered in addition to IFRS measurements, may differ to definitions given by regulatory bodies relevant to the group and to similarly titled measures presented by other companies. They have not been audited, reviewed or verified by the external auditor of Fluidra. For further details on the definition, explanation on the use, and reconciliation of APMs, please see the appendix as well as the “Alternative performance measures” document from our website here (link). DISCLAIMER DISCLAIMER 2
Page 3
| Xavier Tintoré CFO Eloi Planes Executive Chairman Jaime Ramírez CEO 3 ON THE CALL TODAY
Page 4
| • Strong Q3 performance, outperforming the market ▪ Sales up 10% in Q3 and 7% YTD1 with volume growth across all regions, and accelerated growth in Commercial Pool ▪ Good execution of the Simplification Program, compensating unfavorable mix ▪ Improved leverage with net debt to EBITDA ratio at 2.1x, down 0.2x • On track to deliver FY 2025 guidance • Focused on strengthening the business for the long-term and further improving returns ▪ Awarded ‘Vendor of the Year’ by the US top distributors for the fifth year in a row 4 KEY MESSAGES (1) Constant FX and perimeter
Page 5
| YTD financial highlights €M 2024 2025 Evol. 25/24 Const. FX & Perimeter Sales 1,637 1,724 5.3% 6.6% Adjusted EBITDA 386 411 6.4% 8.3% Adjusted EBITA 315 334 6.1% 8.8% Adjusted EPS 1.01 1.11 9.5% Operating net working capital 378 438 16.0% 18.8% Net debt 1,069 1,034 (3.2%) (0.5%) Net debt / LTM Adj. EBITDA 2.3x 2.1x (0.2x) • Sales up strongly, with positive volume and price contribution and growth across all regions • Adjusted EBITDA 8% higher YoY, driven by higher volume while we continue to invest in the business for growth ▪ Adjusted EBITDA margin % diluted by tariffs’ effect ▪ Unfavorable translation effect from weaker USD • Adjusted EPS up 10% on the back of a strong operational performance • Operating NWC at 20% of sales driven by higher receivables • Improved leverage ratio 5 STRONG PERFORMANCE DESPITE UNFAVORABLE FX
Page 6
| Consistent regional growth - higher volume and prices offsetting FX headwind Accelerated price effect to compensate tariffs 6 STRONG EXECUTION AND SHARE GAINS 4.8%1.6%1.0%(2.1%) 1,637 1,724 16 27 79 Sales YTD ’24 FX Perimeter Price Volume Sales YTD ’25 (34) 5.3% Sales YoY % growth at const. FX & perimeter % of Group’s sales Q3 2025 YTD 2025 YTD 2025 Southern Europe 8.3% 3.7% 29% Rest of Europe 2.7% 4.2% 14% North America 13.0% 9.1% 43% Rest of the World 9.4% 7.5% 15% Total 9.5% 6.6% 100%
Page 7
| Awarded ‘Vendor of the Year’ by three top US distributors for the fifth year in a row 7 WINNING WITH OUR CUSTOMERS Customer centricity: Attentive, extensive, committed and consistent support to our customers: • Innovative solutions • High-quality products • Dedicated technical sale support • Availability on time delivery Format to be improved
Page 8
| YTD results €M 2024 % Sales 2025 % Sales Evol. 25/24 Sales 1,637 100% 1,724 100% 5.3% Gross margin 915 55.9% 968 56.1% 5.8% Opex 528 32.3% 556 32.3% 5.3% Adjusted EBITDA 386 23.6% 411 23.9% 6.4% D&A (non-PPA related) 72 4.4% 77 4.5% 7.8% Adjusted EBITA 315 19.2% 334 19.4% 6.1% Amortization (PPA related) 47 2.9% 43 2.5% (9.9%) Restructuring, M&A, integration expenses and SBC 41 2.5% 17 1.0% (58.0%) Financial result 55 3.4% 48 2.8% (12.0%) Income tax expense 45 2.8% 59 3.5% 31.7% Profit/loss attributable to NCI 3 0.2% 3 0.2% (16.3%) Profit/loss attributable to the parent 123 7.5% 163 9.5% 33.0% Adjusted net profit 194 11.9% 213 12.3% 9.5% Notes: SBC = Stock based compensation expense; NCI = Non-controlling interests • Sales up 5% year-on-year, with growth across all regions • Gross margin slightly up YoY benefitting from the Simplification Program, which offsets negative geographic and product mix effects • Operating expenses reflect labor, logistics and general costs inflation together with continued investment in digitalization and growth • Adjusted EBITDA margin % slightly up YoY • Restructuring, M&A and integration expenses significantly down as expected • Strong profit improvement, up 33% YoY • Adjusted net profit 10% up YoY 8 GROWING SALES, ADJUSTED EBITDA AND NET PROFIT
Page 9
|9 Accumulated savings to date Variable cost Fixed cost €31m €93m €100m • Reducing structure overlaps • Global procurement savings • Design to Value (DtV) • SKUs rationalization Expected total gross savings FY 2023 Q3 2025 FY 2025 SIMPLIFICATION PROGRAM ON TRACK AND DELIVERING FY 2024 €68m
Page 10
| Cash flow (abridged) and net debt YTD €M 2024 2025 Evol. 25/24 Adjusted EBITDA 386 411 25 Net interest paid (49) (43) 6 Corporate income tax paid (51) (49) 2 Operating working capital (5) (100) (95) Other operating cash flow(1) (29) (20) 9 CF from operating activities 252 199 (53) Capex (51) (46) 5 Acquisitions / divestments (2) (29) (26) Other investment cash flow 6 (25) (31) CF from investing activities (47) (99) (52) Payments for lease liabilities (32) (35) (3) Treasury stock, net 0 0 (1) Dividends paid (59) (58) 1 Financing cash flow (91) (94) (3) Free cash flow 113 6 (107) Net debt (31 December prior year) 1,172 1,132 (41) FX & lease changes 10 (91) (101) Free cash flow (113) (6) 107 Net debt 1,069 1,034 (34) Lease liabilities (192) (164) 28 Net financial debt 877 870 (6) • CF from operating activities reflects higher investment in working capital on the back of strong growth, which we expect to normalize in Q4 • CF from investing activities reflects completion of the BAC acquisition in Jan 2025 o Completion of Aiper's acquisition is expected in Q4 • Stable Financing cash flow YoY • Improved leverage ratio supported by improved performance and FX tailwind (1) Includes Restructuring, M&A and integration expenses 10 CF REFLECTS STRONG SALES GROWTH WHILE DELEVERAGING
Page 11
| • Strong performance in Q3, on track to deliver FY guidance • Confident in our future: ▪ Global leader in a structurally attractive industry well positioned to consistently generate value into the future ▪ Team focused on long-term value creation and executing strategy: ‐ Accelerate growth ‐ Foster competitive differentiation ‐ Enhance operational excellence 11 SUMMARY Guidance for FY 2025 Guidance @1.13 EURUSD Sales (€M) 2,160 - 2,220 Adjusted EBITDA (€M) 500 - 520 Adjusted EPS (€/share) 1.33 - 1.40 Note: Guidance assumes 1.16 EURUSD for H2 2025
Page 12
APPENDIX
Page 13
|13 WHY FLUIDRA WINS Leaders in customer-centric innovation, connectivity and sustainable pools – creating competitive differentiation Outstanding financial performance – growth and shareholder value creation enables optimal access to capital 1 #1 player with unique footprint and broadest product offering. Focus on operational excellence Excellent M&A track record and consistent capital allocation 2 3 5 Global leader in a structurally attractive industry, with long-term growth underpinned by resilient aftermarket Experienced and talented team4
Page 14
|14 READY FOR OUR NEXT PHASE OF DEVELOPMENT • #1 player worldwide, with diversified presence • Broadest product portfolio in the industry • Gained share to become #2 player in the US 2007-2017 POST IPO – PRE-MERGER 2018-2024 POST MERGER – TODAY Future NEXT PHASE OF GROWTH From €650M to €780M c.2% Sales CAGR 12.7% Adj. EBITDA margin 2017 c.11% average ROCE From €1.3bn to €2.1bn c.8% Sales CAGR 22.7% Adj. EBITDA margin 2024 From 11% to 17% ROCE • Reinforcing leadership and growing in high potential products and regions • Boosting innovation, digital, and product development • Maximizing productivity and efficiency along the value chain +6% to +8% annual sales growth >25% Adj. EBITDA margin >17% ROCE • Mostly European focused, with marginal presence in the US and more exposed to new construction • Restructuring and divesting non-pool businesses • #1 player in Europe and APAC
Page 15
|15 STRATEGY AND ENABLERS TO DELIVER MEDIUM-TERM OBJECTIVES Culture, talent and organization Finance discipline Technology, data and Digital Ongoing transformation Sustainability roadmap Accelerate growth Enhance operational excellence Foster competitive differentiation
Page 16
|16 MEDIUM-TERM FINANCIAL OBJECTIVES Installed base growth Avg. Ticket on Equipment New Build growth Weather Market share gains Inorganic growth Market growth +4% to +6% +2% Additional Fluidra growth +/-1% Medium-term targets Annual sales growth Adjusted EBITDA margin ROCE >25% >17% +6% to+8%
Page 17
| Q3 €M 2024 % Sales 2025 % Sales Evol. 25/24 Const. FX Constant perimeter Const. FX & Perimeter Southern Europe 119 26% 131 26% 9.6% 9.7% 8.3% 8.3% Rest of Europe 68 15% 72 15% 6.1% 6.5% 2.4% 2.7% North America 190 41% 203 41% 6.6% 13.0% 6.6% 13.0% Rest of the World 88 19% 91 18% 3.6% 10.6% 2.4% 9.4% Total 466 100% 497 100% 6.7% 10.7% 5.6% 9.5% 17 SALES BY GEOGRAPHY YTD €M 2024 % Sales 2025 % Sales Evol. 25/24 Const. FX Constant perimeter Const. FX & Perimeter Southern Europe 474 29% 496 29% 4.6% 4.7% 3.7% 3.7% Rest of Europe 227 14% 246 14% 8.0% 7.8% 4.4% 4.2% North America 690 42% 729 42% 5.7% 9.1% 5.7% 9.1% Rest of the World 245 15% 253 15% 3.1% 8.7% 2.0% 7.5% Total 1,637 100% 1,724 100% 5.3% 7.6% 4.4% 6.6%
Page 18
| Q3 €M 2024 % Sales 2025 % Sales Evol. 25/24 Const. FX & Perimeter Pool & Wellness 457 98% 488 98% 6.9% 9.7% Residential 321 69% 337 68% 5.0% 8.0% Commercial 44 9% 50 10% 12.8% 14.2% Residential Pool Water Treatment 73 16% 81 16% 11.0% 13.9% Fluid Handling 19 4% 20 4% 9.3% 11.8% Irrigation, Industrial & Others 9 2% 9 2% (1.0%) 0.0% Total 466 100% 497 100% 6.7% 9.5% 18 SALES BY BUSINESS UNIT YTD €M 2024 % Sales 2025 % Sales Evol. 25/24 Const. FX & Perimeter Pool & Wellness 1,610 98% 1,694 98% 5.2% 6.5% Residential 1,155 71% 1,210 70% 4.8% 6.1% Commercial 143 9% 156 9% 9.2% 9.5% Residential Pool Water Treatment 241 15% 255 15% 5.9% 7.6% Fluid Handling 72 4% 74 4% 2.8% 4.1% Irrigation, Industrial & Others 27 2% 29 2% 9.7% 10.1% Total 1,637 100% 1,724 100% 5.3% 6.6%
Page 19
| YTD €M 2024 2025 Evol. 25/24 Profit/loss before tax 171 226 31.8% Financial result 55 48 (12.0%) D&A 119 120 0.8% Restructuring, M&A and integration expenses 37 13 (63.9%) Stock based compensation expense 4 4 1.3% Adjusted EBITDA 386 411 6.4% 19 RECONCILIATION OF PBT TO ADJUSTED EBITDA
Page 20
| YTD €M 2024 2025 Evol. 25/24 Profit/loss attributable to the parent 123 163 33.0% Restructuring, M&A and integration expenses 37 13 (63.9%) Stock based compensation expense 4 4 1.3% Financial result 55 48 (12.0%) Net interest paid (49) (43) (12.5%) Amortization (PPA related) 47 43 (9.9%) Tax effect on adjustments (23) (16) (29.4%) Total cash adjustments 71 49 (31.0%) Adjusted net profit 194 213 9.5% Share count 192 192 - Adjusted EPS 1.01 1.11 9.5% 20 RECONCILIATION OF PROFIT ATTRIBUTABLE TO THE PARENT TO ADJUSTED EPS
Page 21
| September €M 2024 % LTM sales 2025 % LTM sales Evol. 25/24 Inventories 466 22.6% 471 21.5% 1.2% Trade and other receivables 257 12.4% 323 14.8% 25.9% Trade payables 345 16.7% 356 16.3% 3.3% Operating net working capital 378 18.3% 438 20.0% 16.0% Dividends, earn-outs & others 51 2.5% 58 2.7% 14.0% Total net working capital 327 15.8% 380 17.4% 16.3% 21 NET WORKING CAPITAL
Page 22
| Assets 09/2024 09/2025 Liabilities 09/2024 09/2025 PPE & rights of use 360 353 Share capital 192 192 Goodwill 1,288 1,269 Share premium 1,149 1,149 Other intangible assets 829 748 Retained earnings and other reserves 248 320 Non-current financial assets 22 8 Interim dividends - - Other non-current assets 102 112 Treasury shares (47) (50) Total non-current assets 2,601 2,490 Other comprehensive income 26 (36) Non-controlling interests 10 11 Total equity 1,577 1,585 Bank borrowings and other marketable securities 1,072 1,034 Other non-current liabilities incl. lease 350 299 Inventories 466 471 Total non-current liabilities 1,422 1,333 Trade and other receivables 257 323 Bank borrowings & loans 26 17 Other current financial assets 2 31 Trade and other payables 396 415 Cash and cash equivalents 198 142 Other current liabilities incl. lease 103 109 Total current assets 923 968 Total current liabilities 525 541 Total assets 3,524 3,458 Total equity & liabilities 3,524 3,458 22 INTERIM FINANCIAL POSITION (ABRIDGED)
Page 23
| Fluidra’s financial statements are prepared according to IFRS and other applicable regulation. The financial information presented in this document also includes Alternative Performance Measures (‘APMs’) prepared according to the group’s reporting model. Please note that we have renamed “EBITDA”, “EBITA”, “Cash Net Profit” and “Cash EPS” to “Adjusted EBITDA”, “Adjusted EBITA”, “Adjusted Net Profit” and “Adjusted EPS”, respectively. For further details on the definition, explanation on the use, and reconciliation of APMs, please see the document “Alternative Performance Measures” that can be found within the “Shareholders and Investors” section from the Group’s website here (link). ● 'Opex' (Operational expenditure): refers to the total amount of operating expenses incurred to run the business. It includes 'personnel expenses' plus 'other operating expenses' net of i) 'income from the rendering of services', ii) 'work performed by the group and capitalized as non-current assets', iii) 'profit/loss from sales of fixed assets’, iv) ‘stock based compensation expense’ and v) the relevant portion of 'Restructuring, M&A and integration expenses related’ to 'Opex' ● 'Adjusted EBITDA': means earnings before interests, taxes, depreciation and amortization. It is calculated as 'sales of goods and finished products' less i) 'changes in inventories of finished goods and work in progress and raw material supplies', ii) 'personnel expenses' and iii) 'other operating expenses' net of i) 'income from the rendering of services', ii) 'work performed by the group and capitalized as non-current assets', iii) 'profit/loss from sales of fixed assets' and iv) 'Share in profit/(loss) for the year from investments accounted for using the equity method‘. The resulting figure is adjusted for ‘Stock based compensation expense’ and 'Restructuring, M&A and integration expenses' ● ‘Stock based compensation expense’ and 'Restructuring, M&A and integration expenses’: these expenses do not arise from ordinary business and, though they may be incurred in more than one period, they do not have continuity over time (unlike operating expenses) and they occur at a point in time or are related to a specific event. ‘Stock based compensation expense’ relates to the cost of management’s long-term incentive plan. ‘Restructuring, M&A and integration expenses’ relates primarily to the integration of recently-acquired companies or to restructuring activities, such as the implementation of the Simplification Program that began in the second half of 2022. Most of these costs impact ‘Opex’, although a relatively minor part affects the ‘Gross margin’ ● ‘Adjusted net profit' and ‘Adjusted EPS’: ‘Adjusted net profit’ is defined as ‘Profit/(loss) attributable to equity holders of the parent’ adjusted for i) ‘Restructuring, M&A and integration expenses’, ii) ‘Stock based compensation expense’, iii) ‘Amortization (PPA related)’, iv) the non-cash portion of the financial result and v) the ‘tax effect on adjustments’, which reflects the tax impact corresponding to each of the adjustments described in sections i) to iv). The calculation is performed by applying to each adjustment the tax rate corresponding to the nature and jurisdiction in which arises. ‘Adjusted EPS’ is ‘Adjusted net profit’ divided by the number of Company shares outstanding at the year-end, excluding the effect of treasury shares ● 'Operating net working capital’: is defined as the sum of the balance sheet items i) ‘inventories’ and ii) ‘trade and other receivables’, less ‘trade payables’, which excludes the part of ‘trade and other payables’ that is not entirely related to trading activities (mainly future payments of ordinary dividends and/or future payments of the acquisition price or options agreed with companies acquired, or earn-outs). This adjustment may have a relatively minor impact at the year-end, although it could be particularly relevant to some of the quarterly closings during the year ● 'Net debt', 'Net debt to Adjusted EBITDA ratio' and 'Net financial debt': ‘Net debt’ is calculated as the sum of i) ‘current and non-current bank borrowings and other marketable securities’, ii) ‘current and non-current lease liabilities’ and iii) ‘derivative financial liabilities’, net of i) ‘cash and cash equivalents’, ii) ‘non-current financial assets’, iii) ‘other current financial assets’ and iv) ‘derivative financial instruments’. ‘Net financial debt’ is simply ‘Net debt’ excluding lease liabilities. The ‘net debt/Adjusted EBITDA ratio’ is calculated as ‘Net debt’ divided by ‘Adjusted EBITDA’ generated in the past 12 months ● ‘ROCE’: “Return on Capital Employed” is a return-on-capital measure used in the business. It is calculated as last 12 months “Adjusted EBITA” divided by the sum of “cash equity” and “net debt”. “Cash equity” refers to “total equity” adjusted by €527 million, which reflects the difference between the average share price for the six-month period prior to the announcement of the merger with Zodiac (€7.4 per share, the share exchange value in the merger) and the share price on the completion date (€13.7 per share, the carrying amount of the Zodiac acquisition under IFRS), multiplied by 83 million new shares issued 23 ALTERNATIVE PERFORMANCE MEASURES
Page 24
Thanks for your attention www.fluidra.com Investor_relations@fluidra.com +34 93 724 39 00 Avda. Alcalde Barnils 69 - 08174 Sant Cugat (Barcelona)